News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

TerraPower and Cardinal Health announce manufacturing and distribution agreement for Actinium-225
08/12/2021

Cardinal Health is pleased to announce an agreement with TerraPower that will help advance the next generation of cancer treatment. Working together, the companies will develop and produce Actinium-225, which will be utilized in drug trials involving targeted alpha therapy for diseases such as breast, prostate, colon and neuroendocrine cancers, melanoma and lymphoma. Learn more in today’s press release

More Company News
12/03/2021

Since the onset of COVID-19 in early 2020, nearly every aspect of the global healthcare supply chain has been disrupted, creating shortages or potential shortages of everything from personal...

12/03/2021

By Suzanne Foster, President, Cardinal Health at-Home Solutions Last month I had the opportunity to attend a leadership conference in France through my participation in the Fellows Program with...

11/23/2021

By Ben Brinker, President of International, Medical Segment What are the keys to creating an agile business culture? That’s something I’ve been reflecting on as we go through the process of...

View all company news »

* Required Fields